Mesude Falay

Mesude Falay

Auto-generated profile, based on publicly available information

Mesude Falay

Department of Hematology , TC Saglik Bakanligi Ankara Numune Egitim ve Arastirma Hastanesi , Ankara , Türkiye

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2018 in Turkish Journal of Hematology
Verified
Journal Article
Open access
MFMesude Falay
Mesude Falay
BÖBerna Afacan Öztürk
Berna Afacan Öztürk
KGKürşad Güneş
Kürşad Güneş
YKYasin Kalpakçı
Yasin Kalpakçı
SDSimten Dağdaş
Simten Dağdaş
GOgulsum ozet
gulsum ozet
Atypical chronic lymphocytic leukemia (CLL) is most frequently confused with mantle cell lymphoma (MCL). Several markers may contribute to the diagnosis of CLL. However, there is no consensus on which markers are needed to be used in flow cytometry for the diagnosis of CLL. The aim of the present study was to investigate the role of CD43 and CD200 markers in the differential diagnosis between CLL and MCL. To address this issue, 339 consecutive patients with CLL and MCL were included in the flow cytometry lymphoproliferative disease panel for evaluation of CD43 and CD200 expressions, but not in the Matutes scoring system. CD200 was expressed in 97.3% of atypical CLL cases, whereas it was dimly expressed in only 6.1% of MCL cases. CD43 expression was 95.7% in atypical CLL cases. In the MCL cases, its expression rate was 39.4%. CD43 and CD200 were found to be more valuable markers than CD22, CD79b, and FMC7. CD43 and CD200 could also be considered as definitive markers in atypical CLL patients, for whom the Matutes scoring system remains ineffective.

1 December 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
YKYasin Kalpakci
Yasin Kalpakci
THTuba Hacibekiroglu
Tuba Hacibekiroglu
GTGulay Trak
Gulay Trak
CKCengiz Karacaer
Cengiz Karacaer
TDTaner Demi̇rci̇
Taner Demi̇rci̇
MFMesude Falay
Mesude Falay
SUMMARY BACKGROUND: The COVID-19 pandemic has affected the entire world, posing a serious threat to human health. T cells play a critical role in the cellular immune response against viral infections. We aimed to reveal the relationship between T cell subsets and disease severity. METHODS: 40 COVID-19 patients were randomly recruited in this cross-sectional study. All cases were confirmed by quantitative RT-PCR. Patients were divided into two equivalent groups, one severe and one nonsevere. Clinical, laboratory and flow cytometric data were obtained from both clinical groups and compared. RESULTS: Lymphocyte subsets, CD4+ and CD8+ T cells, memory CD4+ T cells, memory CD8+ T cells, naive CD4+ T cells, effector memory CD4+ T cells, central memory CD4+ T cells, and CD3+CD4+ CD25+ T cells were significantly lower in severe patients. The naive T cell/CD4 + EM T cell ratio, which is an indicator of the differentiation from naive T cells to memory cells, was relatively reduced in severe disease. Peripheral CD4+CD8+ double-positive T cells were notably lower in severe presentations of the disease (median DP T cells 11.12 µL vs 1.95 µL; p< 0.001). CONCLUSIONS: As disease severity increases in COVID-19 infection, the number of T cell subsets decreases significantly. Suppression of differentiation from naive T cells to effector memory T cells is the result of severe impairment in adaptive immune functions. Peripheral CD4+CD8+ double-positive T cells were significantly reduced in severe disease presentations and may be a useful marker to predict disease severity.

1 August 2020 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
SDsimten dağdaş
simten dağdaş
MUMehmet Ali Uçar
Mehmet Ali Uçar
FCFunda Ceran
Funda Ceran
AGAhmet Kursad Gunes
Ahmet Kursad Gunes
MFMesude Falay
Mesude Falay
GOGulsum Ozet
Gulsum Ozet

1 January 2019 in Clinical Laboratory
Verified
Journal Article
Closed access
MFMesude Falay
Mesude Falay
MSMuhittin Abdülkadir Serdar
Muhittin Abdülkadir Serdar
HDHülya Dalgali
Hülya Dalgali
MUMehmet Ali Uçar
Mehmet Ali Uçar
SDsimten dağdaş
simten dağdaş
GOgulsum ozet
gulsum ozet
The scoring system used for chronic lymphocytic leukemia (CLL) cannot make an accurate diagnosis in some cases. Novel markers are available for the differential diagnosis of CLL, especially from MCL. However, these markers are still not incorporated into diagnostic algorithms. We investigated the role of CD43, CD81, CD200, and ROR1 in the differential diagnosis of CLL and their expression in non-CLL cases. We investigated the role of CD43, CD81, CD20, and ROR1 in the differential diagnosis of CLL by incorporating them into the diagnostic panel after studying peripheral blood or bone marrow samples of 165 patients with 8-color flow cytometry. CD43 positivity was a sensitive marker but had a lower specificity for CLL. CD43 had high diagnostic value for CLL (sensitivity 100%, specificity 88.5%, AUC 98.0%). CD200 was a specific marker for CLL (sensitivity 98%, specificity 90%, AUC: 96%). CD81 expression was highest in the MCL cases, with a median expression rate of 68.5% (range: 54 - 82.5%). It was negative in all the CLL cases. For CLL, CD81 negativity had a sensitivity of 95%, a specificity of 82% and an AUC of 92%. ROR1 was positive in all CLL and MCL cases. CD79b, on the other hand, was a fairly sensitive and specific marker for MCL. CD43, CD81, CD200, and ROR1 should be incorporated into diagnostic algorithms for the differential diagnosis of CLL, especially from MCL.

20 August 2018 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
MFMesude Falay
Mesude Falay
MSMehmet Senes
Mehmet Senes
SKSelcuk Korkmaz
Selcuk Korkmaz
TTTuran Turhan
Turan Turhan
MOMurat Okay
Murat Okay
GOGulsum Ozet
Gulsum Ozet

1 July 2019 in Journal of Immunological Methods
Verified
Journal Article
Closed access
MFMesude Falay
Mesude Falay
MSMehmet Senes
Mehmet Senes
SKSelcuk Korkmaz
Selcuk Korkmaz
GZGökmen Zararsız
Gökmen Zararsız
TTTuran Turhan
Turan Turhan
DYDogan Yucel
Dogan Yucel